Acne vulgaris (สิว) is a common, chronic inflammatory disorder of the pilosebaceous unit that affects millions worldwide and can persist from adolescence into adulthood. Clinically, it presents with comedones (open/closed), papules, pustules, nodules, and in more severe cases, cystic or scarring lesions. Beyond cosmetic impact, acne is associated with psychosocial morbidity including reduced self-esteem, anxiety, and depressive symptoms, making comprehensive management important.
At the mechanistic core of acne is follicular hyperkeratinization, abnormal sebum production, microbial influence, and inflammation. Follicular hyperkeratinization leads to microcomedone formation: keratin and sebum obstruct the follicle, creating an anaerobic environment. This environment favors Cutibacterium acnes (formerly Propionibacterium acnes), a commensal organism that becomes pathogenic through changes in skin microecology. C. acnes contributes via lipase activity that generates free fatty acids, which can irritate follicular walls and stimulate innate immune pathways. Concurrently, abnormal androgen-mediated sebaceous gland activity increases sebum volume; sebum serves as a substrate for bacterial growth and triggers inflammatory signaling.
Inflammation is driven by host immune response to microbial products and keratinocyte stress. Activated neutrophils, macrophages, and T-lymphocytes release cytokines and chemokines that amplify lesion development. Inflammatory cascades are influenced by various mediators such as interleukins (e.g., IL-1, IL-8) and tumor necrosis factor-related pathways. This inflammatory milieu explains the transition from non-inflammatory comedones to red, tender papules and pustules.
Risk factors include genetic susceptibility, hormonal influences (androgen excess or fluctuations), certain medications (e.g., systemic corticosteroids, androgenic/anabolic steroids, some anticonvulsants and lithium), occlusive cosmetics or hair products (comedogenicity), and high-glycemic dietary patterns in susceptible individuals. Diet–acne relationships are complex, but evidence supports that high glycemic load may increase insulin and insulin-like growth factor-1 (IGF-1), promoting androgen sensitivity and sebaceous activity. Smoking may worsen acne severity in some populations through oxidative stress and inflammation.
Treatment aims at controlling microcomedones, reducing bacterial load, decreasing inflammation, and preventing scarring. Topical retinoids are foundational for comedonal and inflammatory acne because they normalize desquamation and reduce microcomedone formation by modulating keratinization pathways. Common agents include adapalene, tretinoin, and tazarotene. They also provide anti-inflammatory effects. Benzoyl peroxide is another key topical therapy; it acts through oxidative mechanisms that reduce C. acnes without promoting antibiotic resistance and is effective for papules and pustules. Topical antibiotics such as clindamycin can be effective but should be combined with benzoyl peroxide to mitigate resistance.
For moderate to severe acne or treatment-resistant cases, systemic options are used. Oral antibiotics (e.g., doxycycline or minocycline) can reduce inflammatory lesions; guidelines emphasize limited duration and combination with benzoyl peroxide or topical retinoids to reduce antimicrobial resistance. For hormonal acne, combined oral contraceptives and anti-androgens like spironolactone can be effective, particularly in women with signs of androgen sensitivity. Isotretinoin is indicated for severe nodulocystic acne, scarring acne, or refractory disease; it provides durable remission in many patients by strongly suppressing sebaceous gland activity and altering keratinization and inflammation. Due to teratogenic risk, isotretinoin requires strict pregnancy prevention programs, monitoring, and clinician oversight.
Skin care adjuncts improve outcomes and tolerability: gentle cleansing, non-comedogenic moisturizers, and sunscreen reduce irritation and prevent post-inflammatory hyperpigmentation. Patients should avoid over-exfoliation and harsh scrubs that can worsen inflammation. Lesional procedures (intralesional corticosteroids) may rapidly reduce painful nodules, while physical extraction is generally reserved for comedones under appropriate guidance.
Early treatment is clinically significant because delayed control increases risk of scarring. Scar prevention includes sustained anti-inflammatory therapy and adherence to a regimen with adequate time-to-effect, typically assessing response over 8–12 weeks for many topical regimens. Counseling on realistic expectations, adherence, and side-effect management improves persistence and outcomes.
Finally, address the psychological burden: incorporating patient education, validating concerns, and screening for depression or anxiety when symptoms are prominent supports holistic care. Acne is treatable, and evidence-based approaches targeting its biological drivers can yield clearer skin, reduce lesion recurrence, and minimize long-term sequelae.
Source: [Oxecureofficial] (Behind The Scene Ep.3, Jun 6, 2026)
Oxe’cure: ✨พี่อ๊อกซี่ พกความน่ารักของน้องโฟ้ดโฟ้ดมาเสิร์ฟให้มัมหมีทุกคนค่าาา กับ Behind The Scene Ep.3 4️⃣💚 🥰พี่อ๊อกซี่ขอขอบคุณสำหรับไลก์&แชร์ทุกกำลังใจทุกช่องทางที่มัมหมีทุกคนส่งมาให้นะคะ💚 📍อยากหน้าใสไกลสิวเหมือนน้องโฟ้ดโฟ้ดมาซื้อ Oxe’cure ได้ที่ 7-11, Watsons, Boots, Beautrium,. #breaking
— @Oxecureofficial May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
